Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
799.2 USD | -0.50% | +1.40% | +36.91% |
06:42am | Eli Lilly Reports Positive Trial Results for Crohn's Disease Treatment | MT |
06:27am | China Grants Green Light to Eli Lilly's Diabetes Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.91% | 723B | |
+32.22% | 598B | |
-2.23% | 364B | |
+20.09% | 331B | |
+3.30% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+8.74% | 169B | |
+1.58% | 162B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Leerink Partners Adjusts Price Target on Eli Lilly to $901 From $821